Diagnosis and management of atherosclerotic cardiovascular disease in chronic kidney disease: a review

Roy O. Mathew, Sripal Bangalore, Michael P. Lavelle, Patricia A. Pellikka, Mandeep S. Sidhu, William E. Boden, Arif Asif

Research output: Contribution to journalReview articlepeer-review

55 Scopus citations


Patients with chronic kidney disease (CKD) have a high prevalence of atherosclerotic cardiovascular disease, likely reflecting the presence of traditional risk factors. A greater distinguishing feature of atherosclerotic cardiovascular disease in CKD is the severity of the disease, which is reflective of an increase in inflammatory mediators and vascular calcification secondary to hyperparathyroidism of renal origin that are unique to patients with CKD. Additional components of atherosclerotic cardiovascular disease that are prominent in patients with CKD include microvascular disease and myocardial fibrosis. Therapeutic interventions that minimize cardiovascular events related to atherosclerotic cardiovascular disease in patients with CKD, as determined by well-designed clinical trials, are limited to statins. Data are lacking regarding other available therapeutic measures primarily due to exclusion of patients with CKD from major trials studying cardiovascular disease. Data from well-designed randomized controlled trials are needed to guide clinicians who care for this high-risk population in the management of atherosclerotic cardiovascular disease to improve clinical outcomes.

Original languageEnglish (US)
Pages (from-to)797-807
Number of pages11
JournalKidney international
Issue number4
StatePublished - Apr 1 2017


  • atherosclerotic cardiovascular disease
  • chronic kidney disease
  • diagnosis
  • medical management
  • percutaneous coronary intervention

ASJC Scopus subject areas

  • Nephrology


Dive into the research topics of 'Diagnosis and management of atherosclerotic cardiovascular disease in chronic kidney disease: a review'. Together they form a unique fingerprint.

Cite this